Mergers and Acquisitions News
Most Popular Mergers and Acquisitions Story
UPDATED: Amgen scoops up Micromet tumor-fighting pipeline for $1.2B
Not to be left out of the M&A rush, Amgen said this morning that it will buy German/U.S. cancer drug developer Micromet ($MITI) for $1.16 billion in cash. At $11 a share, the deal gives its Read more...
Latest Headlines
- February 13, 2012
- February 9, 2012
- February 8, 2012
- February 3, 2012
- January 11, 2012
- January 6, 2012
- December 23, 2011
- December 5, 2011
- December 1, 2011
- November 29, 2011
- November 9, 2011
- October 27, 2011
- October 24, 2011
- October 21, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
